Investegate | Company News | Corporate, London Stock Exchange, Regulatory News Headlines Silence Therapeutics appoints Craig Tooman as CFO

By BFN News | 09:23 AM | Wednesday 06 January, 2021
Silence Therapeutics, a biotechnology company that develops gene therapeutic technology based on RNA interference, has announced Craig Tooman as its new chief financial officer and Michael Davidson as a non-executive director of the board.
Tooman has also become a member of the executive leadership team, effective immediately. His career in the biopharmaceutical industry spans more than 30 years, including 15 years of experience as a public company CFO.
Most recently, he was CFO and chief operating officer at Vyome Therapeutics, and prior to this was CFO and then CEO of Aratana Therapeutics where he successfully negotiated a merger with Elanco.

Related Keywords

United States ,University Of Chicago ,Illinois ,Chicago ,Craig Tooman ,Michael Davidson ,Mark Rothera ,Product Development ,Chicago Center ,Clinical Research ,Silence Therapeutics ,Vyome Therapeutics ,Aratana Therapeutics ,Lipid Clinic ,New Amsterdam ,Pharmaceutical Product Development ,ஒன்றுபட்டது மாநிலங்களில் ,பல்கலைக்கழகம் ஆஃப் சிகாகோ ,இல்லினாய்ஸ் ,சிகாகோ ,கிரேக் டூமன் ,மைக்கேல் டேவிட்சன் ,ப்ராடக்ட் வளர்ச்சி ,சிகாகோ மையம் ,மருத்துவ ஆராய்ச்சி ,ம .னம் சிகிச்சை ,கொழுமியம் சிகிச்சையகம் ,புதியது ஆம்ஸ்டர்டாம் ,மருந்து ப்ராடக்ட் வளர்ச்சி ,